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In 1996, reports of laboratory-based
occupational exposure to an aerosolized
marine toxin captivated both the scientific
press (1,2) and the popular press (3,4). The
following year, amid massive fish kills along
the east coast of the United States, public
health ofﬁcials received reports of a variety of
adverse health effects experienced by water-
men who worked in estuaries where large
numbers of ﬁsh were dying (5–7). During the
same period a small number of recreational
water users also reported signs and symptoms
that they attributed to exposure to east coast
estuarine waters (8). In many of these
instances both the fish kills and the adverse
human health effects were attributed to the
presence of a newly identified dinoflagellate
that had recently been given the scientific
name Pfiesteria piscicida Steidinger &
Burkholder (8,9). 
By the summer of 1997, public concern
was mounting, but little was known about
the biology or ecology of P. piscicida, the toxi-
city of the organism, the possible routes of
human exposure, or the potential adverse
human health effects from environmental
exposure to the organism. In an effort to bet-
ter define the extent of the problem, public
health officials from Centers for Disease
Control and Prevention (CDC), eight state
health agencies (Delaware, Florida, Georgia,
Maryland, North Carolina, South Carolina,
Virginia, West Virginia) and the public
health agency of the District of Columbia,
the U.S. Food and Drug Administration, the
National Institute of Environmental Health
Sciences, and the U.S. Environmental
Protection Agency convened to develop the
public health response to possible human
exposure to P. piscicida (10). The potential
for adverse human health effects to occur on a
larger scale than was currently being reported
was a driving force behind this meeting, as
well as the ensuing coordinated state and
federal public health response to this emerg-
ing environmental threat. 
On the basis of local conditions such as
the degree of natural estuarine flushing, six
states (Delaware, Florida, Maryland, North
Carolina, South Carolina, Virginia) identiﬁed
themselves as most likely to be affected by the
presence of P. piscicida in their estuaries. CDC
collaborated with these states to establish a
uniform surveillance system for capturing all
inquiries and symptom reports related to ﬁsh-
kill events (11). Because no method existed to
conﬁrm exposure to P. piscicida, the collabo-
rating public health agencies agreed to use
exposure to estuarine waters as a surrogate for
potential exposure to P. piscicida. From infor-
mation about the initial self-reports of illness,
and a preliminary investigation by CDC and
state ofﬁcials in Maryland, a series of exposure
and symptom criteria were identiﬁed for pos-
sible estuary-associated syndrome (PEAS)
(5,12,13). The state surveillance systems are
supported by cooperative agreements with
CDC and use toll-free numbers to facilitate
reporting to state or local health departments.
The surveillance system is designed to capture
information about the human health effects
potentially due to estuarine exposures and to
tally public concern and the public health sys-
tem burden associated with public inquiries
about the unknown health implications of
Pfiesteria exposure. Details of the multistate
uniform surveillance system are reported in
this monograph (14). 
Concurrent with the initiation of surveil-
lance, three states (Maryland, North Carolina,
Virginia) embarked upon CDC-funded epi-
demiologic studies to assess adverse health
effects among people who have the greatest
likelihood of exposure to P. piscicida, such as
watermen (11). Although the cohort studies
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are scheduled to continue through 2002,
preliminary findings are reported in this
monograph (15,16). 
In October 2000 CDC sponsored the
National Conference on Pfiesteria: From
Biology to Public Health to bring together
Pﬁesteria researchers from many disparate dis-
ciplines actively engaged in Pfiesteria-related
research. The goal of this meeting was to
describe the state of the science and identify
directions for future research. In preparation
for the conference an expert peer-review panel
was commissioned to review the existing liter-
ature and identify research gaps; the summary
of their review is published in this monograph
(17). During the meeting, primary Pﬁesteria
researchers presented previously unpublished
results; the majority of those presentations are
presented as peer-reviewed articles in this
monograph (18–34). The discussion portion
of the conference focused upon researcher-
identiﬁed research gaps. This article summa-
rizes those discussion segments and suggests
directions for further Pﬁesteria research. 
Biology and Chemistry 
of Pﬁesteria Species
Indiscriminate interchangeable use of the
terms “Pﬁesteria piscicida,” “Pﬁesteria species,”
and “Pfiesteria-like organisms” (PLOs) has
been a source of confusion among both the
scientific and lay communities concerned
about Pﬁesteria-related human health effects.
The study of Pﬁesteria and its biology relies on
the accurate identiﬁcation and differentiation
of PLOs and provides a basic framework and
foundation for all Pfiesteria researchers.
Although initially Pfiesteria was identified
using light microscopy, current technology for
species identification uses scanning electron
microscopy, plate tabulation (i.e., counting
the number of plates that cover the organism),
and recently developed molecular techniques
(26,33). Unfortunately, these methods can be
time consuming and costly, and they do not
lend themselves well to field use. There is
speculation that the reason no one has yet iso-
lated Pﬁesteria toxin from estuarine water sam-
ples is because it is a highly unstable molecule
or family of molecules that quickly degrade,
making identiﬁcation and characterization of
the toxin(s) particularly difﬁcult (35). Because
it has been difﬁcult to differentiate Pﬁesteria
species quickly, a new functional species deﬁn-
ition has been proposed that requires an
organism to have a strong attraction to fresh
fish tissues or excreta, toxic activity that is
stimulated by the presence of live fish, and
production of bioactive substances that can
cause ﬁsh disease or death (29). However, the
use of this ecological species deﬁnition instead
of the more traditional molecular or morpho-
logically based system currently in use needs
further research and justiﬁcation. 
The life cycle of Pﬁesteria species is com-
plex and purports to include a number of
amoeboid and chrysophyte cyst stages not
seen in other marine dinoflagellates (1,36).
Unfortunately, some laboratories engaged in
Pfiesteria research report they have not been
able to isolate or find any evidence for the
amoeboid or chrysophyte cyst stage of the life
cycle. Current research suggests that the
transformation from amoebae to dinospore
occurs only when the amoebae are exposed to
fish (29), though the exact process has not
been elucidated. This conclusion is compli-
cated by the fact that fish have associated
amoebae, and these amoebae are inevitably
brought into the tanks with the fish. The
overall absence of standardized culture proto-
cols and mechanisms for interlaboratory vali-
dation of results represent crucial areas of
future research.
Identifying and characterizing the puta-
tive Pfiesteria toxin and understanding what
induces toxin production are central to
understanding the impact the organism has
on the environment and on human health. It
is agreed in the research community that
investigators should focus their efforts on
identifying the suite of enzymes in Pﬁesteria
that triggers toxin production. Other organ-
isms present in cultures could also cause the
toxicity attributed to Pﬁesteria (29). Although
Glasgow et al. (29) reported that their
Pﬁesteria cultures were grown with antibiotics
and antifungals, some researchers at the
CDC-sponsored National Conference on
Pfiesteria were skeptical that all estuarine
bacteria were killed.
Future efforts should concentrate on the
development of techniques to rapidly and
accurately identify PLOs and Pﬁesteria toxin
in the field. The available molecular and
morphological identification methods only
confirm the presence of a particular species,
not whether the species is capable of produc-
ing bioactive compounds that stress or com-
promise ﬁsh. Currently, only one laboratory
facility is dedicated to producing and making
available for analysis large quantities of
culture water from tanks housing toxic
Pfiesteria. Highly toxic cultures of Pfiesteria
must be maintained on fish, which, when
exposed to toxic Pfiesteria, rapidly die and
release materials into the water. The resulting
array of potentially bioactive compounds in
the water further complicates the process of
characterizing the toxin. Given the complexi-
ties of the identification process and the
inﬂuence of potentially confounding factors,
it is likely that signiﬁcant progress in identi-
fying the Pfiesteria toxin will be accom-
plished only by the collaboration and
cooperation of many groups, all bringing to
the research their own expertise and unique
approaches to the problem.
Pathology of Diseased
Estuarine Fish
Large numbers of dead or dying fish with
characteristic punctate lesions (37) have been
considered by both scientiﬁc and lay commu-
nities as indicating the presence of toxic
Pﬁesteria in estuarine waters. However, many
contributing risk factors may lead to adverse
fish health events in estuarine populations,
and researchers must use caution when
attributing a diseased state in ﬁsh to a single
pathway. Diagnostic assessment to determine
probable cause(s) of ﬁsh kills, lesions, or other
adverse ﬁsh health events requires a multidis-
ciplinary approach that includes epidemiol-
ogy, water chemistry and pathology, and
bacteriology and virology of affected fish.
Although there has been much speculation
about the actual role that Pfiesteria or PLOs
play in the development of skin ulcers in ﬁsh,
the gross ulcer is accepted as the end stage of
a multifactorial event that needs to be exam-
ined from its earliest inception to gain a full
understanding of the lesion development
process (38). 
Although the answers will come from
careful laboratory research, public health ofﬁ-
cials must use current information to make
recommendations about human exposure to
estuarine waters. There are concerns that dis-
missing Pfiesteria as a primary cause of fish
lesions may put people in harm’s way, as peo-
ple may perceive Pﬁesteria to be a minimal risk
to humans. All agree that the public needs to
be educated about the possible signiﬁcance of
ﬁsh ulcers and disease and the potential rela-
tionship to human and environmental health.
The presence of lesions or mortalities in a sen-
sitive species of fish such as menhaden may
serve as an important index in assessing the
health of estuarine systems in general. 
During discussions among researchers
attending the CDC-sponsored conference,
several gaps in current knowledge about
Pﬁesteria and PLOs were identiﬁed, including
a) a lack of controlled laboratory studies to
substantiate the current hypotheses regarding
development of skin ulcer epidemics in
estuarine ﬁshery populations where Pﬁesteria/
PLOs are known or suspected to occur; b) a
need for better understanding of the interac-
tion between infectious and noninfectious
risk factors that lead to skin ulcer develop-
ment; c) a need for better understanding of
the interaction among various infectious
agents that lead to skin ulcer development;
and d) the lack of biomarkers that identify
the specific toxin(s) or other stressors that
have caused damage to ﬁsh. Further research
on diseased fish and control populations is
needed before lesions and other manifesta-
tions of disease in ﬁsh can be attributed to the
activity of Pﬁesteria.Emerging areas of Pﬁesteria research
Estuarine Ecology and
Environmental Monitoring
The science of Pﬁesteria focuses not only on
the organism itself but also on the environ-
ment in which it lives. Although researchers
working with Pfiesteria are likely to have a
basic understanding of broad issues such as
general estuarine ecology, the speciﬁc ecology
of Pﬁesteria and environmental monitoring is
more complex and includes topics such as
eutrophication, nutrient enrichment, deter-
mination of causality in a ﬁsh kill, and state
environmental monitoring efforts.
Monitoring the environment for the
presence of Pﬁesteria to gain an understand-
ing about the circumstances under which the
organism thrives is an important effort cur-
rently under way in six states (21,22).
Because of the expense of field monitoring
programs, clearly deﬁned goals are needed so
as not to burden human and financial
resources. Standardized protocols must be
implemented to allow state-by-state compar-
isons. The process of standardization takes
time and is even further complicated because
some research protocols, such as molecular
diagnostics, are rapidly evolving. Hypothesis-
driven monitoring offers the best chance of
understanding the complex ecological rela-
tionships that control Pfiesteria abundance
and that may eventually lead to predictive
capability. Programs that monitor “every-
thing everywhere” and then attempt to find
signiﬁcant correlations are probably not cost
effective. Further, because a positive correla-
tion cannot be interpreted as cause and
effect, such programs may contribute little to
scientiﬁc understanding in complex systems.
Hypothesis-driven monitoring in conjunc-
tion with laboratory experiments to examine
putative relationships is necessary to under-
stand controlling mechanisms. Some states
make use of citizen-based monitoring groups
to provide better coverage of stations. It is
generally agreed that citizens can play a valu-
able role, but potential problems exist with
respect to data uniformity and quality. The
lack of standardized training limits the use-
fulness of these groups. Another difficulty
faced by volunteer monitoring groups is that
the mere presence of Pﬁesteria does not nec-
essarily indicate a problem; Pﬁesteria is often
benign (36,39), unlike other harmful algal
bloom organisms. 
Directions for future research in the areas
of estuarine and Pfiesteria ecology should
focus upon furthering the understanding of
the biochemistry and behavior of Pfiesteria
and similar organisms in an ecological context
and standardizing monitoring protocols. An
important research objective is to identify the
nature of the possible association between the
presence of Pﬁesteria and ﬁsh with lesions or
other adverse health symptoms. Utilizing
public interest in estuarine issues by provid-
ing appropriate training or outreach programs
for volunteers anxious to collect environmen-
tal samples may increase the effectiveness of
Pﬁesteria research.
Molecular, Cell-Based, 
and Bioassay Methods for
Detecting Pﬁesteria Species
and Their Suspected Toxins
A number of laboratory methods are currently
in use or in development to detect and charac-
terize Pﬁesteria species and their suspected tox-
ins. These methods include cell-based and
molecular assays and a bioassay. Cell-based
methods are used to detect the toxin and
guide the fractionation processes (23,36), and
molecular methods are used to detect the
organism (26). Bioassay is used to conﬁrm the
presence of toxic Pfiesteria and to generate
toxic cultures for fractionation and purifica-
tion processes (32). Animal models are used
for research into potential human health
effects (25). The majority of research to detect
the Pﬁesteria organism and toxin incorporates
any or all of these laboratory methods. 
There is concern that quality assurance
and quality control (QA/QC) principles are
not being adequately applied to Pfiesteria
research, particularly in the fish bioassay
method. Because so little is known about the
optimal conditions for growing and main-
taining Pﬁesteria cultures, it may be limiting
at this time to set firmly the physical and
chemical parameters. Laboratories involved in
Pﬁesteria research are encouraged to maintain
good quality laboratory practices. At this
stage of Pfiesteria research, it may be more
beneﬁcial for laboratories to report the condi-
tions under which they successfully culture
Pfiesteria. As more laboratories engage in
QA/QC activities and apply them to cultur-
ing Pfiesteria, specific standardized ranges of
physical and chemical properties can be deter-
mined. To improve the success rate of labora-
tories attempting to culture toxic Pﬁesteria, it
has been suggested that information relevant
to the cultivation of these toxic cultures, as
well as the cultures themselves, be shared
among laboratories conducting Pfiesteria-
related research (32). Fieldwide discussions or
workshops to facilitate the exchange of
knowledge and experience will provide
researchers with the practical information
needed to establish expertise.
In cell-based research, two receptors have
been reported to be biologically responsive to
the Pﬁesteria toxin, the P2X7 receptor and the
N-methyl-D-aspartate (NMDA) neurotrans-
mitter receptor (23,40). At this time there is
insufficient data to allow comment on the
proposed dual activity of the toxin. It is
known, however, that other dinoflagellates
have multiple sites for binding, and that the
potency of some snake, spider, and scorpion
venoms is due to their reaction with more
than one receptor. The toxin-response mecha-
nism will be better understood once a puriﬁed
toxin is identiﬁed.
Studies on rats have provided models for
evaluating the possible human health effects
of exposure to Pfiesteria (25). Significant
learning impairments have been identiﬁed in
the rat model. However, no other nontoxic
dinoﬂagellate species have been tested in this
model, and no other pathology or follow-up
experiments have been conducted on these
rats. Though rats in this study have not yet
been injected with a P2X7 agonist, they have
been injected with an antagonist for the sec-
ond receptor, NMDA. Rats injected with the
NMDA antagonist became neurologically
deficient, though the deficiencies were dif-
ferent from those caused by direct injection
of Pﬁesteria. 
Future research will undoubtedly focus on
the isolation, purification, and characteriza-
tion of the Pfiesteria toxin(s). This will
improve existing methods and aid researchers
in developing new methods to detect the pres-
ence of the toxin in laboratory and ﬁeld sam-
ples. Methods in development to identify the
Pfiesteria organism include antibody probes,
lectin probes, electrochemical methods, and
ﬂuorescent fragment detection. There is also
work under way to differentiate among life
cycles by stage-specific reverse transcriptase-
polymerase chain reaction. In studies to deter-
mine potential human health effects, future
research will involve the application of extracts
of Pfiesteria culture to specific areas in rat
brains to study behavior and pathology. 
Communication and Public
Relations Issues Related to
Pﬁesteria
The possible human health impact of a newly
emerged toxin in east coast waterways caught
immediate media attention and created a
public perception that waters were not safe
for recreation and consumption of ﬁsh could
be dangerous. State-based communication
specialists were faced with the challenge of
protecting public health by communicating
an appropriate level of concern while also rep-
resenting tourism and fishing in an accurate
perspective. Many states initiated hotlines
and used state- and federally sponsored web
sites to disseminate information quickly (19).
However, anecdotal information that engen-
ders fear continues to be a concern for com-
munication and public relations specialists
working on issues relating to Pﬁesteria. 
Discussions during the 2000 conference in
Atlanta identified several points that
researchers felt should be considered in order
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 5 | October 2001 635Rubin et al.
636 VOLUME 109 | SUPPLEMENT 5 | October 2001 • Environmental Health Perspectives
to improve the effectiveness of Pﬁesteria-related
communications efforts. State ofﬁcials stressed
the importance of presenting anecdotal or lim-
ited case reports in a broader context. For
example, millions of people use the waters of
the Chesapeake Bay and the Pamlico Sound
annually without experiencing any sickness,
but this point is frequently lost when a single
swimmer reports adverse effects and the media
implicate Pﬁesteria. There was general consen-
sus that hot lines, websites, and public meet-
ings are important ways to respond to the
often contradictory and problematic informa-
tion available about Pﬁesteria and to raise con-
sciousness about other pressing environmental
matters (19). In addition, the conference par-
ticipants voiced that researchers and public
health officials should be careful to avoid
assigning blame or to overstate or understate
the health threat of Pﬁesteria. Past carelessness
has resulted in an overly alarmed public and a
farming community whose members believe
they have been mistakenly maligned. It is
important to provide accurate and up-to-date
information about ongoing research to raise
public awareness without causing alarm. To
this end, public health agencies should refer to
and use peer-reviewed literature in developing
Pﬁesteria fact sheets. 
On a positive note, the Pﬁesteria issue has
resulted in a great deal of multidisciplinary
exchange of information and ideas and has
produced an active multi-interest group con-
versation about environmental issues. This
multidisciplinary involvement can only
strengthen Pﬁesteria-related communications
and beneﬁt the public.
P. piscicida and Human Health
It is debatable whether it is appropriate at this
time to use traditional epidemiological tools
(e.g., surveillance and cohort studies of highly
exposed people) to study the potential human
health effects of Pﬁesteria. When the original
state-based studies were defined, researchers
were confident that identification of a bio-
marker of human exposure to Pﬁesteria toxin
was imminent. Development of such a bio-
marker has proved to be much more complex
than anticipated and has severely impaired the
usefulness of epidemiological studies. The
ﬁndings of ongoing cohort studies will have to
be interpreted with great caution, especially
since there has not been a large-scale Pﬁesteria-
related ﬁsh kill since 1997. However, cohort
study investigators note that the ongoing
studies carefully address low-dose chronic
exposure (15) and strive to identify subtle
neurological effects. Biological samples are
being banked for analysis when a serological
test is developed. 
Human health effects could be most
deﬁnitively assigned if researchers conducted
a controlled volunteer-exposure study.
However, such studies cannot yet be con-
ducted because in the absence of the toxin,
the long-term effects that may be associated
with Pﬁesteria exposure are as yet undeﬁned.
Recent research has suggested that visual
contrast sensitivity (VCS) testing may be an
informative tool for diagnosing PEAS (16,41).
PEAS is the syndrome associated with the col-
lection of signs and symptoms exhibited by
persons who report exposure to estuarine water
or laboratory or aquaculture work involving
estuarine water within 2 weeks prior to symp-
tom onset (14,42). VCS testing is controversial
because abnormal ﬁndings are not toxin-spe-
ciﬁc and abnormal ﬁndings can be interpreted
only cautiously unless accompanied by other
fairly extensive visual tests. At this point, a bat-
tery of visual performance testing is not com-
patible with the cohort-testing format.
The need for a biomarker of human expo-
sure to Pﬁesteria toxin remains the single criti-
cal barrier to defining human health
outcomes related to exposure to Pfiesteria
toxin. To better interpret clinical findings,
especially subtle ﬁndings that may more accu-
rately be attributed to agents other than
Pﬁesteria, it is critical that a ﬁeld-based test to
assess Pﬁesteria toxin in water samples and a
test to identify a marker of exposure in
human biological samples be developed.
Conclusion
The future direction of Pﬁesteria research can
and should be guided by discussion among
researchers who are actively engaged in one of
the varied components of Pfiesteria-related
research. When these researchers met in
Atlanta in the fall of 2000, they identified
two research areas of primary importance in
ﬁlling existing knowledge gaps and advancing
the science so that we can address more deﬁn-
itively the question of the threat that
Pﬁesteria poses to human health. Conference
attendees agreed that identification of the
Pﬁesteria toxin and the development of a test
for biomarkers of the toxin in humans were
the most crucial areas for Pﬁesteria research. It
was further recognized that achieving these
goals would require collaboration and sharing
of information among individuals currently
involved in various aspects of Pfiesteria
research. It is only with a multidisciplinary
and collaborative approach that the environ-
mental and public health significance of
Pﬁesteria will be fully understood.
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